Summary
Madivi Jamuna, a seven-year-old Class 2 student from Gollaguppa village in Andhra Pradesh's Polavaram district, died on September 2, 2026. She had been given a chloroquine tablet during an anti-malaria drive in her village in the last week of August.
Over 50 villagers, mostly children, fell ill after the drive and were treated at Bhadrachalam Area Hospital in neighbouring Telangana. All of them except the girl recovered and were discharged. Chief Minister N. Chandrababu Naidu ordered a probe and Chief Justice of India Surya Kant took suo motu cognizance and asked the Andhra Pradesh High Court to monitor it.
The tablet batch has been sent to the Forensic Science Laboratory in Visakhapatnam to check for contamination. The cause of death has not been established.
WHY IN NEWS FOR UPSC & STATE PCS
The Supreme Court has taken suo motu cognizance of the death of a seven-year-old tribal girl who fell ill after receiving a chloroquine tablet during an anti-malaria drive in Polavaram district, Andhra Pradesh. Chief Justice of India Surya Kant has asked the Andhra Pradesh High Court to monitor the State government's probe.
Investigators are awaiting laboratory results on whether the tablet batch was contaminated and the batch has been sent to the Forensic Science Laboratory in Visakhapatnam. The case raises questions about screening, dosing and emergency readiness during mass drug drives in remote tribal areas.
Standard News
The Arithmetic of a Drive and the Child It Counts
The easy reading and why it fails The easy reading of the Polavaram tragedy is a search for a culprit: a contaminated batch, a careless health worker or an indifferent department.
The probe may yet find one. The cause of Madivi Jamuna's death has not been established and the tablet batch is still being tested at the Forensic Science Laboratory in Visakhapatnam. The ethical question does not have to wait for that result.
Whatever the laboratory finds, a district health officer must decide what the next drive will look like. That decision rests on a tension built into every mass health campaign.
Two kinds of duty in one tablet The logic of the drive is utilitarian and it is a serious logic. In malaria-endemic tribal areas, reaching every household quickly saves lives by reducing transmission across the whole community. Coverage targets exist because each household that is skipped is a place where the disease can survive. The duty to each child is individual and it is just as serious. A tablet that is safe for a village in the aggregate is still swallowed by one particular child, with a particular weight and health condition, living a particular distance from the nearest hospital. In this case, over 50 villagers, mostly children, needed hospital care after the drive and they were treated across the State border at Bhadrachalam in Telangana.
What the
officer is caught between Imagine you are the district health officer with the next round of the drive due.
- If you push ahead at the old pace, you protect the coverage that keeps malaria down, but you send the same process back into villages that have just watched a child die, without knowing whether that process was at fault.
- If you suspend the drive until every report is in, you protect against a repeat, but malaria does not stop while files are pending. Children in the same villages may then fall seriously ill from the disease the drive was meant to prevent. Both choices put children at risk and the officer has to decide which risk he is willing to take responsibility for.
What must change before the next drive The answer is neither to push ahead as before nor to stop indefinitely.
It is to rebuild the drive around the individual child before restarting it:
- Withdraw the suspect batch and use only stock that has been separately tested.
- Dose by weight, not by guesswork: carry a weighing scale and a dosing chart into every village and screen each child with a short checklist before giving the tablet.
- Prepare for emergencies: keep a medical team, an emergency kit and a vehicle on standby during each drive, with a pre-arranged referral route to a hospital.
- Follow up actively: health workers should revisit households within a day or two and report every adverse reaction immediately.
- Seek consent and explain honestly, in the community's own language, what the drug is, what reactions to watch for and where to go if something goes wrong. All of this will slow the drive and some coverage targets will be missed this season. That is a real cost, because malaria will reach some households before the drive does. It is still the right trade, because a drive that a frightened village refuses will cover nobody.
Quick Facts
Key numbers & takeaways — revise these first
-
Chloroquine is a long-established medicine used to treat and prevent malaria.
-
For children, chloroquine is dosed according to body weight.
-
Madivi Jamuna, a seven-year-old from Gollaguppa village in Polavaram district, died on September 2, 2026 after an anti-malaria drive.
-
Over 50 villagers, mostly children, were treated at Bhadrachalam Area Hospital in Telangana after the drive and all except the girl recovered.
-
The tablet batch has been sent to the Forensic Science Laboratory in Visakhapatnam to test for contamination.
-
Suo motu cognizance means a court takes up a matter on its own, without a petition being filed.
-
The National Vector Borne Disease Control Programme (NVBDCP) is India's central programme for controlling vector-borne diseases such as malaria.
Connect the dots for your UPSC preparation.
Standard news covers the event. Log in to read our comprehensive analysis and uncover the hidden constitutional, structural, and ethical dimensions of this topic:
The full dilemma from the district health officer's desk, with the cost of pushing ahead and the cost of suspending the drive named for the same villages
Why the utilitarian case for mass drives is strong and where Kantian duty, non-maleficence and the right to life under Article 21 draw a firm limit
How a pharmacovigilance model similar to the one used for vaccines could be adapted to drug drives in remote tribal areas
A step-by-step resolution of what must change before the next drive, together with the coverage and malaria risk it openly accepts in the meantime
Included in this analysis
Join thousands of aspirants analyzing the news deeply.
Unlock Premium — Rs.699 AnnuallyDon't have an account? Sign up for free